Dialysis services provider Nephrocare Health Services Ltd, known for its brand NephroPlus, is set to launch its initial public offering, co...

December promises a surge in India's IPO market, with around 25 public issues worth nearly ₹30,000 crore planned. This follows a record-bre...

Dialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising...

India's IPO market anticipates a blockbuster November, with over ₹76,000 crore in public issues expected across various sectors. This surge...

IPO-bound NephroCare Health Services on Wednesday said it has scaled its operations from one clinic in India in 2010 to 500 clinics, across...

Quadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...

Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...

Nephrocare Health Services, known as NephroPlus, plans to raise funds through an IPO. The IPO includes fresh shares and an offer for sale. ...

Nephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 cr...

Manipal group chairman Ranjan Pai’s family office Claypond Capital has anchored the fund with capital infusion from over 30 startup founder...

Quadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...

Quadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India's largest dialysis chain...

“The company has reached out to mid-size private equity funds to raise up to Rs 250 crore as a pre-IPO round,” said one of the persons with...